Metastatic Colorectal Cancers Withdrawn Phase 2 Trials for Celecoxib (DB00482)

Back to Metastatic Colorectal Cancers

Also known as: Metastatic Colorectal Cancer / Colorectal Cancer Metastatic / Cancer - Metastatic Colorectal / Metastatic Colorectal Cancer (MCRC) / Colorectal Cancer, Metastatic / Secondary malignant neoplasm of colon and/or rectum (disorder) / Secondary malignant neoplasm of large intestine (disorder)

Indication	Status	Phase
DBCOND0063579 (Metastatic Colorectal Cancers)	Withdrawn	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02615574	A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer	Treatment	Celecoxib (DB00482)